ScholarIQanswers from OpenAlex

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

PaperCitations, authors & open-access status

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma have?

ScholarIQcitation count

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma has 71 citations in the OpenAlex counts ScholarIQ stores.

When was Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma published?

ScholarIQyear

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma has 2022 year in the ScholarIQ index.

What is the open-access status of Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma?

ScholarIQoa status

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma has hybrid oa status in the ScholarIQ index.

What is the DOI of Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma?

ScholarIQdoi

The DOI for Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma is on the source record.

What is the PMID of Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma?

ScholarIQpmid

The PMID for Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma is on the source record.

What is the OpenAlex record for Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma?

ScholarIQopenalex

The OpenAlex for Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial